Autosomal dominant polycystic kidney

MeSH D016891 - autosomal dominant polycystic kidney

Favorite

Competitive Landscape

Events Timeline

Commercial

Clinical Trials

Competitive landscape

See list view

D007690:Polycystic kidney diseases

0 Companies

0 Drugs

Success rate

D016891:

Autosomal dominant polycystic kidney

1 Company

1 Drug

Success rate

Events Timeline

Commercial

Company Name	Drug Name	Trade Name	Patent Expires	Approval Date	Revenue	Period
Otsuka	Tolvaptan	Jinarc		2015-05-27

Clinical Trials

Historical Success Rate

Phase 1

67%

2/3

Phase 2

63%

10/16

Phase 3

31%

4/13

Approved: 1Overall Success rate: 13%

All Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Company name

Phase 1

Phase 2

Phase 3

Phase 4

Drug Name

Otsuka

Tolvaptan,

Ademetionine,

Sodium polystyrene sulfonate